FHL-601

N/A

Report date: 2023/09/04 17:39:23
NME

Base Information

Drug NameFHL-601
Drug Alias NameFHL-601
ClassificationOther
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesForest Hills Lab
China Registration ClassN/A

Develop Information

Active CompaniesForest Hills Lab
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A